nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Methotrexate—germ cell cancer	0.226	1	CbGbCtD
Penicillamine—Alveolitis allergic—Ifosfamide—germ cell cancer	0.0223	0.0288	CcSEcCtD
Penicillamine—Guillain-Barre syndrome—Methotrexate—germ cell cancer	0.019	0.0245	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Bleomycin—germ cell cancer	0.0155	0.02	CcSEcCtD
Penicillamine—Trauma—Bleomycin—germ cell cancer	0.0143	0.0185	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Ifosfamide—germ cell cancer	0.0132	0.0171	CcSEcCtD
Penicillamine—Peptic ulcer—Vinblastine—germ cell cancer	0.0121	0.0156	CcSEcCtD
Penicillamine—Interstitial pneumonia—Ifosfamide—germ cell cancer	0.012	0.0156	CcSEcCtD
Penicillamine—Alveolitis allergic—Methotrexate—germ cell cancer	0.0106	0.0136	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Etoposide—germ cell cancer	0.0105	0.0135	CcSEcCtD
Penicillamine—Eruption—Dactinomycin—germ cell cancer	0.0103	0.0134	CcSEcCtD
Penicillamine—Leukaemia—Methotrexate—germ cell cancer	0.0102	0.0132	CcSEcCtD
Penicillamine—Interstitial lung disease—Bleomycin—germ cell cancer	0.00963	0.0124	CcSEcCtD
Penicillamine—Interstitial pneumonia—Etoposide—germ cell cancer	0.00952	0.0123	CcSEcCtD
Penicillamine—Extravasation—Vinblastine—germ cell cancer	0.00925	0.012	CcSEcCtD
Penicillamine—Interstitial lung disease—Ifosfamide—germ cell cancer	0.00823	0.0106	CcSEcCtD
Penicillamine—Coagulopathy—Dactinomycin—germ cell cancer	0.00816	0.0106	CcSEcCtD
Penicillamine—Optic neuritis—Cisplatin—germ cell cancer	0.00816	0.0106	CcSEcCtD
Penicillamine—Extravasation—Bleomycin—germ cell cancer	0.00781	0.0101	CcSEcCtD
Penicillamine—Cholestasis—Ifosfamide—germ cell cancer	0.00767	0.00991	CcSEcCtD
Penicillamine—Coagulopathy—Ifosfamide—germ cell cancer	0.00748	0.00967	CcSEcCtD
Penicillamine—Optic neuritis—Etoposide—germ cell cancer	0.00748	0.00967	CcSEcCtD
Penicillamine—Extravasation—Dactinomycin—germ cell cancer	0.00728	0.00942	CcSEcCtD
Penicillamine—Extravasation—Ifosfamide—germ cell cancer	0.00667	0.00863	CcSEcCtD
Penicillamine—Proteinuria—Ifosfamide—germ cell cancer	0.00663	0.00857	CcSEcCtD
Penicillamine—Protein urine present—Ifosfamide—germ cell cancer	0.00654	0.00845	CcSEcCtD
Penicillamine—Interstitial lung disease—Etoposide—germ cell cancer	0.0065	0.0084	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Methotrexate—germ cell cancer	0.00626	0.0081	CcSEcCtD
Penicillamine—Ageusia—Cisplatin—germ cell cancer	0.0062	0.00801	CcSEcCtD
Penicillamine—Vasculitis—Ifosfamide—germ cell cancer	0.00597	0.00771	CcSEcCtD
Penicillamine—Aplastic anaemia—Dactinomycin—germ cell cancer	0.00597	0.00771	CcSEcCtD
Penicillamine—Extravasation—Cisplatin—germ cell cancer	0.00575	0.00744	CcSEcCtD
Penicillamine—Mouth ulceration—Dactinomycin—germ cell cancer	0.00575	0.00743	CcSEcCtD
Penicillamine—Interstitial pneumonia—Methotrexate—germ cell cancer	0.0057	0.00737	CcSEcCtD
Penicillamine—Appetite absent—Methotrexate—germ cell cancer	0.00554	0.00716	CcSEcCtD
Penicillamine—Injury—Bleomycin—germ cell cancer	0.00538	0.00696	CcSEcCtD
Penicillamine—Extravasation—Etoposide—germ cell cancer	0.00527	0.00681	CcSEcCtD
Penicillamine—Hepatic failure—Dactinomycin—germ cell cancer	0.00513	0.00664	CcSEcCtD
Penicillamine—Thrombophlebitis—Ifosfamide—germ cell cancer	0.00488	0.00631	CcSEcCtD
Penicillamine—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00484	0.00625	CcSEcCtD
Penicillamine—Pancytopenia—Vinblastine—germ cell cancer	0.00481	0.00621	CcSEcCtD
Penicillamine—Neuropathy—Cisplatin—germ cell cancer	0.00471	0.00609	CcSEcCtD
Penicillamine—Hepatic failure—Ifosfamide—germ cell cancer	0.0047	0.00608	CcSEcCtD
Penicillamine—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00468	0.00605	CcSEcCtD
Penicillamine—Eruption—Methotrexate—germ cell cancer	0.00448	0.00579	CcSEcCtD
Penicillamine—Neuropathy peripheral—Vinblastine—germ cell cancer	0.00442	0.00572	CcSEcCtD
Penicillamine—Neuropathy—Etoposide—germ cell cancer	0.00432	0.00558	CcSEcCtD
Penicillamine—Agranulocytosis—Vinblastine—germ cell cancer	0.00421	0.00544	CcSEcCtD
Penicillamine—Mouth ulceration—Etoposide—germ cell cancer	0.00416	0.00538	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00415	0.00537	CcSEcCtD
Penicillamine—Bone marrow depression—Methotrexate—germ cell cancer	0.00408	0.00528	CcSEcCtD
Penicillamine—Haemoglobin—Vinblastine—germ cell cancer	0.00407	0.00526	CcSEcCtD
Penicillamine—Pancytopenia—Bleomycin—germ cell cancer	0.00406	0.00525	CcSEcCtD
Penicillamine—Haemorrhage—Vinblastine—germ cell cancer	0.00405	0.00524	CcSEcCtD
Penicillamine—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00404	0.00522	CcSEcCtD
Penicillamine—Interstitial lung disease—Methotrexate—germ cell cancer	0.00389	0.00503	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Etoposide—germ cell cancer	0.00384	0.00496	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00381	0.00492	CcSEcCtD
Penicillamine—Pancytopenia—Dactinomycin—germ cell cancer	0.00379	0.00489	CcSEcCtD
Penicillamine—Stomatitis—Bleomycin—germ cell cancer	0.00372	0.0048	CcSEcCtD
Penicillamine—Haematuria—Bleomycin—germ cell cancer	0.00363	0.0047	CcSEcCtD
Penicillamine—Pancreatitis—Ifosfamide—germ cell cancer	0.00358	0.00463	CcSEcCtD
Penicillamine—Alopecia—Vinblastine—germ cell cancer	0.00358	0.00463	CcSEcCtD
Penicillamine—Pancytopenia—Ifosfamide—germ cell cancer	0.00347	0.00449	CcSEcCtD
Penicillamine—Stomatitis—Dactinomycin—germ cell cancer	0.00346	0.00448	CcSEcCtD
Penicillamine—Haemoglobin—Bleomycin—germ cell cancer	0.00344	0.00445	CcSEcCtD
Penicillamine—Haemorrhage—Bleomycin—germ cell cancer	0.00342	0.00442	CcSEcCtD
Penicillamine—Agranulocytosis—Dactinomycin—germ cell cancer	0.00332	0.00429	CcSEcCtD
Penicillamine—Anaemia—Vinblastine—germ cell cancer	0.00326	0.00421	CcSEcCtD
Penicillamine—Renal failure—Ifosfamide—germ cell cancer	0.0032	0.00414	CcSEcCtD
Penicillamine—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.00319	0.00413	CcSEcCtD
Penicillamine—Stomatitis—Ifosfamide—germ cell cancer	0.00318	0.0041	CcSEcCtD
Penicillamine—Extravasation—Methotrexate—germ cell cancer	0.00316	0.00408	CcSEcCtD
Penicillamine—Leukopenia—Vinblastine—germ cell cancer	0.00316	0.00408	CcSEcCtD
Penicillamine—Proteinuria—Methotrexate—germ cell cancer	0.00314	0.00405	CcSEcCtD
Penicillamine—Haematuria—Ifosfamide—germ cell cancer	0.00311	0.00402	CcSEcCtD
Penicillamine—Protein urine present—Methotrexate—germ cell cancer	0.00309	0.004	CcSEcCtD
Penicillamine—Pancreatitis—Cisplatin—germ cell cancer	0.00309	0.00399	CcSEcCtD
Penicillamine—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00308	0.00398	CcSEcCtD
Penicillamine—Agranulocytosis—Ifosfamide—germ cell cancer	0.00304	0.00393	CcSEcCtD
Penicillamine—Alopecia—Bleomycin—germ cell cancer	0.00302	0.00391	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00301	0.00389	CcSEcCtD
Penicillamine—Pancytopenia—Cisplatin—germ cell cancer	0.00299	0.00387	CcSEcCtD
Penicillamine—Glossitis—Methotrexate—germ cell cancer	0.00299	0.00386	CcSEcCtD
Penicillamine—Haemoglobin—Ifosfamide—germ cell cancer	0.00294	0.0038	CcSEcCtD
Penicillamine—Haemorrhage—Ifosfamide—germ cell cancer	0.00292	0.00378	CcSEcCtD
Penicillamine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00289	0.00373	CcSEcCtD
Penicillamine—Urethral disorder—Ifosfamide—germ cell cancer	0.00287	0.00371	CcSEcCtD
Penicillamine—Vasculitis—Methotrexate—germ cell cancer	0.00282	0.00365	CcSEcCtD
Penicillamine—Alopecia—Dactinomycin—germ cell cancer	0.00282	0.00365	CcSEcCtD
Penicillamine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00282	0.00364	CcSEcCtD
Penicillamine—Renal failure—Cisplatin—germ cell cancer	0.00276	0.00357	CcSEcCtD
Penicillamine—Anaemia—Bleomycin—germ cell cancer	0.00275	0.00356	CcSEcCtD
Penicillamine—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00275	0.00356	CcSEcCtD
Penicillamine—Anorexia—Vinblastine—germ cell cancer	0.00274	0.00355	CcSEcCtD
Penicillamine—Pancytopenia—Etoposide—germ cell cancer	0.00274	0.00354	CcSEcCtD
Penicillamine—Stomatitis—Cisplatin—germ cell cancer	0.00274	0.00354	CcSEcCtD
Penicillamine—Tinnitus—Ifosfamide—germ cell cancer	0.00273	0.00352	CcSEcCtD
Penicillamine—Leukopenia—Bleomycin—germ cell cancer	0.00267	0.00345	CcSEcCtD
Penicillamine—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00266	0.00343	CcSEcCtD
Penicillamine—Angiopathy—Ifosfamide—germ cell cancer	0.00265	0.00343	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—germ cell cancer	0.00259	0.00334	CcSEcCtD
Penicillamine—Alopecia—Ifosfamide—germ cell cancer	0.00258	0.00334	CcSEcCtD
Penicillamine—Anaemia—Dactinomycin—germ cell cancer	0.00257	0.00332	CcSEcCtD
Penicillamine—Mental disorder—Ifosfamide—germ cell cancer	0.00256	0.00331	CcSEcCtD
Penicillamine—Renal failure—Etoposide—germ cell cancer	0.00253	0.00327	CcSEcCtD
Penicillamine—Neuropathy peripheral—Etoposide—germ cell cancer	0.00252	0.00326	CcSEcCtD
Penicillamine—Stomatitis—Etoposide—germ cell cancer	0.00251	0.00324	CcSEcCtD
Penicillamine—Decreased appetite—Vinblastine—germ cell cancer	0.0025	0.00323	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—germ cell cancer	0.00249	0.00322	CcSEcCtD
Penicillamine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00249	0.00322	CcSEcCtD
Penicillamine—Leukopenia—Dactinomycin—germ cell cancer	0.00249	0.00321	CcSEcCtD
Penicillamine—Urethral disorder—Cisplatin—germ cell cancer	0.00247	0.00319	CcSEcCtD
Penicillamine—Hepatobiliary disease—Etoposide—germ cell cancer	0.00243	0.00315	CcSEcCtD
Penicillamine—Agranulocytosis—Etoposide—germ cell cancer	0.0024	0.0031	CcSEcCtD
Penicillamine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00238	0.00308	CcSEcCtD
Penicillamine—Anaemia—Ifosfamide—germ cell cancer	0.00235	0.00304	CcSEcCtD
Penicillamine—Tinnitus—Cisplatin—germ cell cancer	0.00235	0.00304	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—germ cell cancer	0.00234	0.00303	CcSEcCtD
Penicillamine—Agitation—Ifosfamide—germ cell cancer	0.00234	0.00302	CcSEcCtD
Penicillamine—Anorexia—Bleomycin—germ cell cancer	0.00232	0.003	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—germ cell cancer	0.00231	0.00299	CcSEcCtD
Penicillamine—Urinary tract disorder—Etoposide—germ cell cancer	0.00228	0.00295	CcSEcCtD
Penicillamine—Leukopenia—Ifosfamide—germ cell cancer	0.00228	0.00295	CcSEcCtD
Penicillamine—Urethral disorder—Etoposide—germ cell cancer	0.00226	0.00293	CcSEcCtD
Penicillamine—Alopecia—Cisplatin—germ cell cancer	0.00223	0.00288	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—germ cell cancer	0.00223	0.00288	CcSEcCtD
Penicillamine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00222	0.00287	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00221	0.00286	CcSEcCtD
Penicillamine—Arthralgia—Ifosfamide—germ cell cancer	0.00217	0.0028	CcSEcCtD
Penicillamine—Anorexia—Dactinomycin—germ cell cancer	0.00216	0.00279	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00215	0.00278	CcSEcCtD
Penicillamine—Hypersensitivity—Vinblastine—germ cell cancer	0.00212	0.00274	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00212	0.00274	CcSEcCtD
Penicillamine—Decreased appetite—Bleomycin—germ cell cancer	0.00211	0.00273	CcSEcCtD
Penicillamine—Angiopathy—Etoposide—germ cell cancer	0.0021	0.00271	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00207	0.00267	CcSEcCtD
Penicillamine—Alopecia—Etoposide—germ cell cancer	0.00204	0.00264	CcSEcCtD
Penicillamine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00203	0.00263	CcSEcCtD
Penicillamine—Anaemia—Cisplatin—germ cell cancer	0.00203	0.00262	CcSEcCtD
Penicillamine—Skin disorder—Ifosfamide—germ cell cancer	0.00202	0.00261	CcSEcCtD
Penicillamine—Anorexia—Ifosfamide—germ cell cancer	0.00198	0.00256	CcSEcCtD
Penicillamine—Decreased appetite—Dactinomycin—germ cell cancer	0.00197	0.00255	CcSEcCtD
Penicillamine—Diarrhoea—Vinblastine—germ cell cancer	0.00197	0.00255	CcSEcCtD
Penicillamine—Dysgeusia—Etoposide—germ cell cancer	0.00197	0.00255	CcSEcCtD
Penicillamine—Leukopenia—Cisplatin—germ cell cancer	0.00196	0.00254	CcSEcCtD
Penicillamine—Urticaria—Bleomycin—germ cell cancer	0.00193	0.0025	CcSEcCtD
Penicillamine—Body temperature increased—Bleomycin—germ cell cancer	0.00192	0.00248	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00189	0.00245	CcSEcCtD
Penicillamine—Anxiety—Cisplatin—germ cell cancer	0.00186	0.00241	CcSEcCtD
Penicillamine—Anaemia—Etoposide—germ cell cancer	0.00186	0.0024	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00186	0.0024	CcSEcCtD
Penicillamine—Vomiting—Vinblastine—germ cell cancer	0.00183	0.00237	CcSEcCtD
Penicillamine—Decreased appetite—Ifosfamide—germ cell cancer	0.00181	0.00233	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.0018	0.00233	CcSEcCtD
Penicillamine—Leukopenia—Etoposide—germ cell cancer	0.0018	0.00233	CcSEcCtD
Penicillamine—Body temperature increased—Dactinomycin—germ cell cancer	0.00179	0.00232	CcSEcCtD
Penicillamine—Hypersensitivity—Bleomycin—germ cell cancer	0.00179	0.00232	CcSEcCtD
Penicillamine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00175	0.00227	CcSEcCtD
Penicillamine—Skin disorder—Cisplatin—germ cell cancer	0.00174	0.00225	CcSEcCtD
Penicillamine—Asthma—Methotrexate—germ cell cancer	0.00173	0.00223	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—germ cell cancer	0.00171	0.00221	CcSEcCtD
Penicillamine—Nausea—Vinblastine—germ cell cancer	0.00171	0.00221	CcSEcCtD
Penicillamine—Anorexia—Cisplatin—germ cell cancer	0.00171	0.00221	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0017	0.0022	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—germ cell cancer	0.00169	0.00219	CcSEcCtD
Penicillamine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00167	0.00216	CcSEcCtD
Penicillamine—Urticaria—Ifosfamide—germ cell cancer	0.00165	0.00213	CcSEcCtD
Penicillamine—Body temperature increased—Ifosfamide—germ cell cancer	0.00164	0.00212	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—germ cell cancer	0.00164	0.00212	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00163	0.00211	CcSEcCtD
Penicillamine—Thrombocytopenia—Etoposide—germ cell cancer	0.00161	0.00208	CcSEcCtD
Penicillamine—Skin disorder—Etoposide—germ cell cancer	0.00159	0.00206	CcSEcCtD
Penicillamine—Anorexia—Etoposide—germ cell cancer	0.00156	0.00202	CcSEcCtD
Penicillamine—Decreased appetite—Cisplatin—germ cell cancer	0.00156	0.00201	CcSEcCtD
Penicillamine—Diarrhoea—Dactinomycin—germ cell cancer	0.00155	0.00201	CcSEcCtD
Penicillamine—Vomiting—Bleomycin—germ cell cancer	0.00155	0.002	CcSEcCtD
Penicillamine—Rash—Bleomycin—germ cell cancer	0.00153	0.00198	CcSEcCtD
Penicillamine—Dermatitis—Bleomycin—germ cell cancer	0.00153	0.00198	CcSEcCtD
Penicillamine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00153	0.00198	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—germ cell cancer	0.00151	0.00196	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—germ cell cancer	0.0015	0.00194	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—germ cell cancer	0.00147	0.0019	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00146	0.00188	CcSEcCtD
Penicillamine—Nausea—Bleomycin—germ cell cancer	0.00144	0.00187	CcSEcCtD
Penicillamine—Vomiting—Dactinomycin—germ cell cancer	0.00144	0.00186	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—germ cell cancer	0.00144	0.00186	CcSEcCtD
Penicillamine—Rash—Dactinomycin—germ cell cancer	0.00143	0.00185	CcSEcCtD
Penicillamine—Decreased appetite—Etoposide—germ cell cancer	0.00143	0.00184	CcSEcCtD
Penicillamine—Diarrhoea—Ifosfamide—germ cell cancer	0.00142	0.00184	CcSEcCtD
Penicillamine—Body temperature increased—Cisplatin—germ cell cancer	0.00142	0.00183	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—germ cell cancer	0.00139	0.0018	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—germ cell cancer	0.00138	0.00179	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00137	0.00177	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—germ cell cancer	0.00136	0.00175	CcSEcCtD
Penicillamine—Nausea—Dactinomycin—germ cell cancer	0.00135	0.00174	CcSEcCtD
Penicillamine—Vomiting—Ifosfamide—germ cell cancer	0.00132	0.00171	CcSEcCtD
Penicillamine—Hypersensitivity—Cisplatin—germ cell cancer	0.00132	0.00171	CcSEcCtD
Penicillamine—Rash—Ifosfamide—germ cell cancer	0.00131	0.00169	CcSEcCtD
Penicillamine—Dermatitis—Ifosfamide—germ cell cancer	0.00131	0.00169	CcSEcCtD
Penicillamine—Urticaria—Etoposide—germ cell cancer	0.0013	0.00169	CcSEcCtD
Penicillamine—Body temperature increased—Etoposide—germ cell cancer	0.0013	0.00168	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—germ cell cancer	0.00129	0.00167	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—germ cell cancer	0.00126	0.00162	CcSEcCtD
Penicillamine—Nausea—Ifosfamide—germ cell cancer	0.00123	0.0016	CcSEcCtD
Penicillamine—Diarrhoea—Cisplatin—germ cell cancer	0.00123	0.00158	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—germ cell cancer	0.00122	0.00158	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—germ cell cancer	0.00121	0.00157	CcSEcCtD
Penicillamine—Hypersensitivity—Etoposide—germ cell cancer	0.00121	0.00156	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—germ cell cancer	0.00118	0.00152	CcSEcCtD
Penicillamine—Vomiting—Cisplatin—germ cell cancer	0.00114	0.00147	CcSEcCtD
Penicillamine—Rash—Cisplatin—germ cell cancer	0.00113	0.00146	CcSEcCtD
Penicillamine—Dermatitis—Cisplatin—germ cell cancer	0.00113	0.00146	CcSEcCtD
Penicillamine—Diarrhoea—Etoposide—germ cell cancer	0.00112	0.00145	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—germ cell cancer	0.00111	0.00144	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—germ cell cancer	0.00108	0.00139	CcSEcCtD
Penicillamine—Nausea—Cisplatin—germ cell cancer	0.00106	0.00138	CcSEcCtD
Penicillamine—Vomiting—Etoposide—germ cell cancer	0.00104	0.00135	CcSEcCtD
Penicillamine—Rash—Etoposide—germ cell cancer	0.00103	0.00134	CcSEcCtD
Penicillamine—Dermatitis—Etoposide—germ cell cancer	0.00103	0.00134	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—germ cell cancer	0.00103	0.00133	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00102	0.00132	CcSEcCtD
Penicillamine—Nausea—Etoposide—germ cell cancer	0.000975	0.00126	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000962	0.00124	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—germ cell cancer	0.000955	0.00123	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—germ cell cancer	0.000937	0.00121	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000895	0.00116	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—germ cell cancer	0.000854	0.0011	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—germ cell cancer	0.000781	0.00101	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—germ cell cancer	0.000777	0.001	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—germ cell cancer	0.000724	0.000936	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—germ cell cancer	0.000672	0.000869	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—germ cell cancer	0.000625	0.000808	CcSEcCtD
Penicillamine—Rash—Methotrexate—germ cell cancer	0.00062	0.000801	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—germ cell cancer	0.000619	0.0008	CcSEcCtD
Penicillamine—Nausea—Methotrexate—germ cell cancer	0.000584	0.000755	CcSEcCtD
